Google’s AlphaGenome 2 zooms in on the cellular roots of disease

Google DeepMind has released AlphaGenome 2, an AI model capable of predicting how genetic variants affect specific cell types and biological states. This tool aims to help researchers identify the cellular roots of diseases and accelerate the discovery of new treatments.
Why it matters
Advancements in AI-driven genomics could significantly improve our understanding of complex diseases and lead to more personalized medical interventions.
Researchers at Google DeepMind have unveiled a new AI model designed to unravel how changes in our DNA affect different cells, giving scientists a more detailed view of a notoriously difficult problem that could hold important clues to the causes of disease — and point the way to new treatments.
AlphaGenome 2 is the successor to DeepMind’s genome-predicting AI model AlphaGenome, which was released last year. While nearly every cell in the human body carries the same DNA, different types of cells — from heart muscle cells and skin cells to immune cells fighting an infection — switch different genes on and off, and those patterns can change depending on what a cell is doing. As a result, the same genetic variant can have very different effects depending on the type and state of the cell.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in